E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/4/2024 in the Prospect News Convertibles Daily.

New Issue: Medartis sells CHF 115.8 million 3% guaranteed convertible bonds due 2031, up 27.5%

By Cristal Cody

Tupelo, Miss., April 4 – Medartis Holding AG announced Thursday that it priced CHF 115.8 million of 3% senior unsecured guaranteed convertible bonds due 2031, according to a notice.

The bonds were issued by subsidiary Medartis International Finance SAS and unconditionally and irrevocably guaranteed by the parent company.

Advanced subscription rights for existing shareholders were excluded in the offering.

The bonds are convertible into newly issued and/or existing registered shares of the company.

The initial conversion price of the bonds has been set at CHF 100.725, representing a premium of 27.5% over the price per share in the concurrent delta placement.

Price talk was for a coupon of 2.75% to 3.25% and an initial conversion premium of 25% to 30%.

The bonds may be redeemed at par starting May 2, 2029, subject to a 130% hurdle.

BofA Securities Europe SA was the sole global coordinator. Zurcher Kantonalbank joined as a joint bookrunner.

Medartis said the joint bookrunners have conducted a simultaneous placement of existing shares of the company in order to facilitate hedging the market risk for certain subscribers of the bonds. Medartis said it will not receive any proceeds from the placement of those shares.

An application will be made for the bonds to be admitted to trading on the Open Market of the Frankfurt Stock Exchange and such admission to trading is expected no later than three months after the settlement date.

Proceeds from the deal will be used for general funding purposes including acquisitions in Medartis’ core business.

Medartis is a specialized orthopaedic company for head and extremity surgery based in Basel, Switzerland.

Issuer:Medartis International Finance SAS
Guarantor:Medartis Holding AG
Amount:CHF 115.8 million
Issue:Convertible senior guaranteed notes
Maturity:April 11, 2031
Bookrunners:BofA Securities Europe SA and Zurcher Kantonalbank
Coupon:3%
Price:Par
Yield:3%
Conversion premium:27.5%
Conversion price:CHF 100.725
Call features:At par starting May 2, 2029, subject to 130% hurdle
Puts:At par on fifth anniversary
Trade date:April 4
Settlement date:April 11
Distribution:Regulation S
Price talk:Coupon of 2.75% to 3.25%, initial conversion premium of 25% to 30%
Stock symbol:SWX: MED
Stock price:CHF 87.3 on April 3
Market capitalization:CHF 1 billion

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.